DBV Technologies

DBV Technologies is a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with food allergies and other immunological diseases. Founded by pediatricians, the company has focused on developing innovative treatments using its proprietary Viaskin™ technology platform. Viaskin™ is an epicutaneous immunotherapy (EPIT™) patch designed to re-educate the immune system by introducing minimal amounts of antigen to the skin. The company is currently investigating Viaskin™ for peanut, milk, and egg allergies, and is exploring its potential for other immunologic diseases.

DBV Technologies has a robust clinical development program with ongoing Phase 3 trials for its Viaskin™ Peanut treatment. The company is also exploring diagnostic applications for its technology and has an ongoing partnership with Nestlé Health Science to develop a patch test for the diagnosis of cow’s milk protein allergy. DBV Technologies is headquartered in Châtillon, France, with North American operations in Warren, New Jersey. Its ordinary shares are traded on Euronext Paris and its ADSs are traded on the Nasdaq Stock Market.

DBV Technologies offers an agile, fast-paced work environment that encourages creativity and flexibility for employees passionate about therapeutic advancements. The company promotes a competitive and innovative approach to attracting and retaining employees, offering generous benefits that align with its core values of Curiosity, Courage, Collaboration, and Credibility. This allows employees to engage in creative scientific exploration, be part of a small but international team, and contribute to major developments in service of patients.

DBV Technologies offers an agile, fast-paced environment for employees passionate about therapeutic advancements. The company provides a competitive and innovative approach to attracting and retaining employees, offering a generous benefits philosophy aligned with their company culture and 4Cs core values. This philosophy aims to recognize employee performance, strengthen internal equity, and promote employee development. The benefits package includes competitive salary and incentive programs, recognition programs, internal career development resources, and a comprehensive healthcare plan.

DBV Technologies is a global clinical-stage biopharmaceutical company committed to improving the lives of patients with food allergies and other immunological diseases. Founded by pediatricians passionate about finding safe and effective treatments, DBV focuses on advancing epicutaneous immunotherapy (EPIT) through its innovative Viaskin™ technology platform. This non-invasive approach aims to re-educate the immune system, offering potential treatment options for food allergies, inflammatory conditions, and autoimmune diseases. DBV's mission is to develop a pipeline of Viaskin™ product candidates that could transform the care of patients with unmet medical needs.

DBV Technologies fosters a culture of innovation and collaboration, where employees are encouraged to take smart risks and push boundaries. They value curiosity, courage, collaboration, and credibility – the "4Cs" – which guide their work towards developing safe and effective treatments for patients with food allergies and other immunological diseases. This translates to an agile, fast-paced environment that attracts and retains passionate individuals who are committed to making a difference in the lives of those affected by these conditions.

DBV Technologies is committed to diversity, equity and inclusion, believing that a diverse workforce is essential for innovation and success. They celebrate the full expression of their four core values, known as the 4Cs – Curiosity, Courage, Collaboration, and Credibility – which are rooted in the DNA of the company. This commitment is reflected in their diverse and multicultural workforce with a wide range of job skills, academic backgrounds, career histories, and experiences. DBV Technologies provides equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, gender identity, national origin, age, disability, veteran status, or genetics.